Procalcitonin is useful in driving the choice of early antibiotic treatment in patients with bloodstream infections

被引:6
作者
Murri, R. [1 ]
Mastrorosa, I. [1 ]
Taccari, F. [1 ]
Baroni, S. [2 ]
Giovannenze, F. [1 ]
Palazzolo, C. [1 ]
Lardo, S. [1 ]
Scoppettuolo, G. [1 ]
Ventura, G. [1 ]
Cauda, R. [1 ]
Fantoni, M. [1 ]
机构
[1] Univ Cattolica Sacro Cuore, A Gemelli Fdn, Sch Med, Dept Infect Dis, Rome, Italy
[2] Univ Cattolica Sacro Cuore, A Gemelli Fdn, Sch Med, Lab Clin Chem, Rome, Italy
关键词
Procalcitonin; Bloodstream infection; Candidemia; Antibiotic stewardship; CRITICALLY-ILL PATIENTS; SEPSIS; MARKER; DEFINITIONS; BACTEREMIA; CANDIDEMIA; ENDOTOXIN; MORTALITY;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
OBJECTIVE: To evaluate whether PCT levels could be used to distinguish among different bacterial and fungal etiologies in patients with documented bloodstream infection (BSI). PATIENTS AND METHODS: Monocentric retrospective cohort study on patients admitted to the Fondazione Policlinico Gemelli Hospital between December 2012 and November 2015 with BSI. Those who had undergone PCT determination within 48 hours of when the first positive blood culture was sampled were included in the study. RESULTS: Four hundred and one patients were included in the study. Both the 24h and 48h PCT values were significantly higher in patients with Gram-negative (GN) BSI than in those with Gram-positive (GP) or candida BSI (p at ANOVA = 0.003). A PCT value of > 1 ng/ml was found in 31.5% of patients with GN BSI. Less than 7% of people with candida BSI had PCT level of > 1 ng/ml. At multivariable regression analysis, GN BSI, septic shock, and plasma creatinine were significantly correlated with PCT values. CONCLUSIONS: PCT may be of value in distinguishing GN BSI from GP, and fungal BSI and PCT values of > 1 ng/ml could be used to prevent unnecessary antifungal treatment.
引用
收藏
页码:3130 / 3137
页数:8
相关论文
共 32 条
[1]   HIGH SERUM PROCALCITONIN CONCENTRATIONS IN PATIENTS WITH SEPSIS AND INFECTION [J].
ASSICOT, M ;
GENDREL, D ;
CARSIN, H ;
RAYMOND, J ;
GUILBAUD, J ;
BOHUON, C .
LANCET, 1993, 341 (8844) :515-518
[2]   Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial [J].
Bouadma, Lila ;
Luyt, Charles-Edouard ;
Tubach, Florence ;
Cracco, Christophe ;
Alvarez, Antonio ;
Schwebel, Carole ;
Schortgen, Frederique ;
Lasocki, Sigismond ;
Veber, Benoit ;
Dehoux, Monique ;
Bernard, Maguy ;
Pasquet, Blandine ;
Regnier, Bernard ;
Brun-Buisson, Christian ;
Chastre, Jean ;
Wolff, Michel .
LANCET, 2010, 375 (9713) :463-474
[3]   Significantly higher procalcitonin levels could differentiate Gram-negative sepsis from Gram-positive and fungal sepsis [J].
Brodska, Helena ;
Malickova, Karin ;
Adamkova, Vaclava ;
Benakova, Hana ;
Stastna, Marketa Markova ;
Zima, Tomas .
CLINICAL AND EXPERIMENTAL MEDICINE, 2013, 13 (03) :165-170
[4]   Serum procalcitonin measurement contribution to the early diagnosis of candidemia in critically ill patients [J].
Charles, Pierre Emmanuel ;
Dalle, Frederic ;
Aho, Serge ;
Quenot, Jean-Pierre ;
Doise, Jean-Marc ;
Aube, Herve ;
Olsson, Nils-Olivier ;
Blettery, Bernard .
INTENSIVE CARE MEDICINE, 2006, 32 (10) :1577-1583
[5]   Serum procalcitonin elevation in critically ill patients at the onset of bacteremia caused by either gram negative or gram positive bacteria [J].
Charles, Pierre Emmanuel ;
Ladoire, Sylvain ;
Aho, Serge ;
Quenot, Jean-Pierre ;
Doise, Jean-Marc ;
Prin, Sebastien ;
Olsson, Niels-Olivier ;
Blettery, Bernard .
BMC INFECTIOUS DISEASES, 2008, 8 (1)
[6]   Procalcitonin as a marker of Candida species detection by blood culture and polymerase chain reaction in septic patients [J].
Cortegiani, Andrea ;
Russotto, Vincenzo ;
Montalto, Francesca ;
Foresta, Grazia ;
Accurso, Giuseppe ;
Palmeri, Cesira ;
Maurizio, Santi Raineri ;
Giarratano, Antonino .
BMC ANESTHESIOLOGY, 2014, 14
[7]   PROCALCITONIN INCREASE AFTER ENDOTOXIN INJECTION IN NORMAL SUBJECTS [J].
DANDONA, P ;
NIX, D ;
WILSON, MF ;
ALJADA, A ;
LOVE, J ;
ASSICOT, M ;
BOHUON, C .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1994, 79 (06) :1605-1608
[8]   Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients: a randomised, controlled, open-label trial [J].
de Jong, Evelien ;
van Oers, Jos A. ;
Beishuizen, Albertus ;
Vos, Piet ;
Vermeijden, Wytze J. ;
Haas, Lenneke E. ;
Loef, Bert G. ;
Dormans, Tom ;
van Melsen, Gertrude C. ;
Kluiters, Yvette C. ;
Kemperman, Hans ;
van den Elsen, Maarten J. ;
Schouten, Jeroen A. ;
Streefkerk, Joern O. ;
Krabbe, Hans G. ;
Kieft, Hans ;
Kluge, Georg H. ;
van Dam, Veerle C. ;
van Pelt, Joost ;
Bormans, Laura ;
Otten, Martine Bokelman ;
Reidinga, Auke C. ;
Endeman, Henrik ;
Twisk, Jos W. ;
van de Garde, Ewoudt M. W. ;
de Smet, Anne Marie G. A. ;
Kesecioglu, Jozef ;
Girbes, Armand R. ;
Nijsten, Maarten W. ;
de lange, Dylan W. .
LANCET INFECTIOUS DISEASES, 2016, 16 (07) :819-827
[9]  
DELLINGER RP, 2013, INTENS CARE MED, V39, P165, DOI DOI 10.1007/s00134-012-2769-8
[10]   Contribution of Toll-like receptors to the innate immune response to Gram-negative and Gram-positive bacteria [J].
Elson, Greg ;
Dunn-Siegrist, Irene ;
Daubeuf, Bruno ;
Pugin, Jerome .
BLOOD, 2007, 109 (04) :1574-1583